Thursday 19 April 2012 - Register Now

Genmab (DK)

Genmab is an international biotechnology company with world class discovery and development teams that use cutting edge technology to create and develop human antibodies to revolutionize the treatment of cancer. Our goal: improve patients' lives and build a profitable and successful biotech company that maximizes value for patients and shareholders.